Skip to main content

Month: May 2024

Wereldhave was assigned Long-Term Issuer Default Rating and senior unsecured rating of ‘BBB’ from Fitch Ratings

Wereldhave N.V. (“Wereldhave”) is pleased to announce that Fitch Ratings has assigned a Long-Term Issuer Default Rating (IDR) and senior unsecured rating of ‘BBB’ to Wereldhave. The Outlook on the IDR is Stable. This public rating reflects the company’s strengthened financial position and solid operational performance. Enhanced balance sheet Wereldhave’s balance sheet has shown significant improvement, supported by the strategic acquisition of Polderplein and the related successful share issue in December 2023. These actions have strengthened the company’s financial profile and reduced leverage. Performance of Full Service Centers The transformation of Wereldhave’s shopping centers into Full Service Centers continues to yield positive results. These centers, offering a mix of retail, leisure, and essential services,...

Continue reading

LifeStance Health Group Announces Pricing of Secondary Public Offering

SCOTTSDALE, Ariz., May 21, 2024 (GLOBE NEWSWIRE) — LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced the pricing of a secondary underwritten public offering of 20,000,000 shares of LifeStance’s common stock, par value $0.01 per share (the “Common Stock”) at a public offering price of $6.25 per share, pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the “SEC”). The underwriters will have a 30-day option to purchase up to an additional 3,000,000 shares of Common Stock from certain stockholders of the Company (the “Selling Stockholders”). The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares...

Continue reading

Falco Thanks the Community for Its Participation at the BAPE Public Information Session

ROUYN-NORANDA, Quebec, May 21, 2024 (GLOBE NEWSWIRE) — Falco Resources Ltd. (TSX.V: FPC) (“Falco” or the “Corporation”) provides a positive assessment of the public information meeting of the Bureau d’audiences publiques sur l’environnement (“BAPE”) held on May 21st at the Petit Théâtre du Vieux-Noranda. More than 200 people came for information and to ask questions about Falco’s Horne 5 Project (“Falco’s Horne 5 Project” or the “Project”) not counting webcast participants, which demonstrates the population’s high level of interest in the Project for all the surrounding communities. This public information session allowed the population and various organizations to obtain details on the Project and answers on subjects of concern to them. Falco’s team has been engaged and listening to citizens since day one. To that effect, Falco...

Continue reading

Dyne Therapeutics Announces Pricing of $325.5 Million Public Offering of Common Stock

WALTHAM, Mass., May 21, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the pricing of an underwritten public offering of 10,500,000 shares of its common stock at a public offering price of $31.00 per share. The gross proceeds to Dyne from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Dyne, are expected to be $325.5 million. All shares in the offering are being sold by Dyne. The offering is expected to close on or about May 24, 2024, subject to customary closing conditions. In addition, Dyne has granted the underwriters a 30-day option to purchase up to an additional 1,575,000 shares of its...

Continue reading

Carbon Streaming Announces Landmark Azuero Reforestation Carbon Removal Project in Collaboration With Rubicon Carbon, Ponterra, and Microsoft

The Azuero Reforestation Project Will Restore 10,000 Hectares of Degraded Land in Panama with Over 75 Native Tree Species TORONTO, May 21, 2024 (GLOBE NEWSWIRE) — Carbon Streaming Corporation (Cboe CA: NETZ) (OTCQB: OFSTF) (FSE: M2Q) (“Carbon Streaming” or the “Company”), in collaboration with Microsoft Corporation (“Microsoft”) and Rubicon Carbon Capital LLC (“Rubicon”), is pleased to announce that it has entered into a carbon credit streaming agreement (the “Azuero Reforestation Stream”) with Azuero Reforestación Colectiva, S.A. (“ARC”), a wholly owned subsidiary of leading project developer Ponterra Ltd. (“Ponterra”), for the ARC Restauro Azura project (the “Azuero Reforestation Project” or the “Project”) located in Panama. Deal HighlightsThe Project is expected to generate 3.24 million carbon removal credits through...

Continue reading

Imperial Drilling Intersects 257.5 Metres Grading 0.71% Copper and 0.39 g/t Gold at Mount Polley

VANCOUVER, British Columbia, May 21, 2024 (GLOBE NEWSWIRE) — Imperial Metals Corporation (“Imperial” or the “Company”) (TSX:III) reports diamond drill results from three more holes of the Mount Polley 2024 exploration program, including a notable interval of 257.5 metres grading 0.71% copper and 0.39 g/t gold from 35.0 metres in diamond drill hole SD-24-180. This phase of drilling is ongoing and is following up on the significant results obtained in the 2023 drill programs. Hole SD-24-180 was a vertical hole located 33 metres northwest from previously released hole SD-24-179 which intersected 270 metres grading 0.65% copper and 0.48 g/t gold from 22.5 metres on section 3230N. Holes SD-24-180 and SD-24-179 were planned to target gaps in the southwest edge of the Springer Pit at both shallow and deep levels. The first 135.5 metres...

Continue reading

Bombardier Announces Pricing of its New Issuance of Senior Notes due 2032

MONTRÉAL, May 21, 2024 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier”) today announced that it has successfully priced its offering of US$750 million aggregate principal amount of new Senior Notes due June 1, 2032. The new Senior Notes will carry a coupon of 7.000% per annum and will be sold at par (the “New Notes”). The issuance of the New Notes is expected to close on or about June 5, 2024, subject to customary closing conditions. Bombardier intends to use the proceeds of the offering of the New Notes, together with cash on hand, (i) to fund the repayment and/or retirement of outstanding indebtedness, including the redemption of US$338 million aggregate principal amount of its outstanding 7.125% Senior Notes due 2026 (the “2026 Notes”, and such redemption, the “Conditional 2026 Notes Redemption”) and the redemption of US$450...

Continue reading

Bombardier Announces Conditional Notices of Partial Redemption for US$338,000,000 of its 7.125% Senior Notes due 2026 and US$450,000,000 of its 7.875% Senior Notes due 2027 

MONTRÉAL, May 21, 2024 (GLOBE NEWSWIRE) — Bombardier Inc. (“Bombardier”) today announced that it has issued a conditional notice of partial redemption for US$338 million aggregate principal amount of its outstanding 7.125% Senior Notes due 2026 (the “2026 Notes”), and a conditional notice of partial redemption for US$450 million aggregate principal amount of its outstanding 7.875% Senior Notes due 2027 (the “2027 Notes” and, together with the 2026 Notes, the “Redemption Notes”). As set forth in the conditional notice of partial redemption issued today in respect of the 2026 Notes, the redemption date is June 20, 2024, and the redemption price for the 2026 Notes is 101.781% of the principal amount redeemed, plus accrued and unpaid interest. As set forth in the conditional notice of partial redemption issued today in respect of the...

Continue reading

Pliant Therapeutics Presents Data from its Bexotegrast Program at the American Thoracic Society International Conference

SOUTH SAN FRANCISCO, Calif., May 21, 2024 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced that the Company presented clinical data and preclinical data of bexotegrast (PLN-74809) this week as part of the American Thoracic Society (ATS) 2024 International Conference, held from May 17-22, 2024. “Our 2024 ATS presentations include comprehensive clinical safety and imaging data, as well as preclinical data from our bexotegrast development program that provide further support the late-stage development of this novel therapeutic in our currently enrolling BEACON-IPF trial,” said Éric Lefebvre, M.D., Chief Medical Officer at Pliant Therapeutics. Update on the Safety...

Continue reading

Neon Bloom Finalizes Terms to Acquire Advanced Executive Sales, LLC

Acquisition and expansion into payment processing expected to close before May 31, 2024 NEWPORT BEACH, Calif., May 21, 2024 (GLOBE NEWSWIRE) — Neon Bloom, Inc. (OTC PINK: NBCO), announced today that it has finalized the terms of its acquisition of Advanced Executive Sales, LLC (AES), a leading financial services company specializing in electronic payment and card processing for all types of businesses. The two companies expect to close on the acquisition by May 31, 2024. After months of due diligence and negotiations between Neon Bloom and Mr. Greg Bauer, the Managing Member of AES, the two parties finally came to a mutual agreement as to the structure and consideration for the acquisition. As part of the final agreement, Neon Bloom will be appointing Mr. Bauer as a member of the Neon Bloom Board of Directors and an executive officer...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.